Abstract
A 5.5-year-old child with nephrotic syndrome was treated with cyclophosphamide. After 9 weeks of therapy she developed jaundice and abnormal liver function tests. No infective aetiology was found and the abnormal liver function tests resolved within 5 weeks of discontinuing cyclophosphamide. Cyclophosphamide has rarely been reported to cause liver dysfunction, but not in children treated for nephrotic syndrome, and paediatricians should therefore be aware of its potential for inducing reversible hepatic dysfunction.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Aubrey DH (1970) Massive hepatic necrosis after cyclophosphamide. BMJ 3:588
Bacon AM, Rosenberg SA (1982) Cyclophosphamide hepatotoxicity in a patient with systemic lupus crythematosus. Ann Intern Med 97:62–63
Cleland BD, Pokorny CS (1993) Cyclophosphamide related hepatotoxicity. Aust NZ J Med 23:408
Goldberg JW, Lidsky MD (1985) Cyclophosphamide-associated hepatotoxicity. South Med J 78:222–223
Rollins BJ (1986) Hepatic veno-occlusive disease. Am J Med 81:297–306
Van Steenbergen W, Vanstapel MJ, Desmet V, Van Kerckvoorde L, De Keyzer R, Brijs R, Fevery J, De Groote J (1985) Cimetidine-induced liver injury. Report of three cases. J Hepatol 1:359–368
Villeneuve JP, Warner HA (1979) Cimetidine hepatitis. Gastroenterology 77:143–144
Walters D, Robinson RG, Dick-Smith JB, Corrigan AB, Webb J (1972) Poor response in two cases of juvenile rheumatoid arthritis to treatment with cyclophosphamide. Med J Aust 2:1070
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Milford, D.V., Butler, N., Clarke, R. et al. Reversible hepatic dysfunction in association with cyclophosphamide therapy. Eur J Pediatr 154, 411–412 (1995). https://doi.org/10.1007/BF02072117
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02072117